These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 826207

  • 1. Discussion paper: experimental and clinical immunopharmacology data applicable to cancer immunotherapy.
    Mathé G, Schwarzenberg L, Halle-Pannenko O, Simmler MC.
    Ann N Y Acad Sci; 1976; 277(00):467-84. PubMed ID: 826207
    [No Abstract] [Full Text] [Related]

  • 2. Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man.
    Mathé G, Hayat M, Amiel JL, Schwarzenberg L, Schneider M, Pouillart P, Cattan A.
    Boll Ist Sieroter Milan; 1971; 50(4):251-9. PubMed ID: 5293498
    [No Abstract] [Full Text] [Related]

  • 3. Post-surgical systematic active immunotherapy: rational and experimental basis.
    Mathé G, Olsson L, Florentin I, Kiger N, Orbach-Arbouys S, Schulz JI.
    Recent Results Cancer Res; 1979; 67():132-50. PubMed ID: 377432
    [No Abstract] [Full Text] [Related]

  • 4. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G, Weiner R, Pouillart P, Schwarzenberg L, Jasmin C, Schneider M, Hayat M, Amiel JL, de Vassal F, Rosenfeld C.
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract] [Full Text] [Related]

  • 5. Discussion paper: effect of hemolytic streptococci on lymphocytic leukemia in AKR mice.
    Havas HF.
    Ann N Y Acad Sci; 1976 Dec; 277(00):299-301. PubMed ID: 1069550
    [No Abstract] [Full Text] [Related]

  • 6. Immunochemotherapy of human cancer.
    Gutterman JU, Mavligit GM, Reed RC, Hersh EM.
    Semin Oncol; 1974 Dec; 1(4):409-23. PubMed ID: 4620443
    [No Abstract] [Full Text] [Related]

  • 7. Immunotherapy of leukaemia.
    Malpas JS.
    Schweiz Med Wochenschr; 1974 May 04; 104(18):626-33. PubMed ID: 4596725
    [No Abstract] [Full Text] [Related]

  • 8. Active immunotherapy.
    Mathé G.
    Adv Cancer Res; 1971 May 04; 14():1-36. PubMed ID: 4330473
    [No Abstract] [Full Text] [Related]

  • 9. Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
    Mathe G.
    Comp Immunol Microbiol Infect Dis; 1980 May 04; 3(4):407-32. PubMed ID: 6451350
    [No Abstract] [Full Text] [Related]

  • 10. [Active immunotherapy of L 1210 leukemia given after the graft of the tumor].
    Mathé G.
    Rev Fr Etud Clin Biol; 1968 Nov 04; 13(9):881-3. PubMed ID: 5304470
    [No Abstract] [Full Text] [Related]

  • 11. Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man.
    Mathé G, Amiel JL, Schwarzenberg L, Schneider M, Pouillart P, Cattan A.
    Bibl Haematol; 1970 Nov 04; (36):678-88. PubMed ID: 5293620
    [No Abstract] [Full Text] [Related]

  • 12. Immunotherapy of cancer in man: current status and prospectus.
    Carter SK.
    Ann N Y Acad Sci; 1976 Nov 04; 277(00):722-40. PubMed ID: 793477
    [No Abstract] [Full Text] [Related]

  • 13. Immunology and colonic cancer: cancer immunotherapy results in leukemias--experimental and clinical approaches to the treatment of solid tumors.
    Mathé G, Thompson RB.
    Dis Colon Rectum; 1973 Nov 04; 16(5):341-57. PubMed ID: 4590448
    [No Abstract] [Full Text] [Related]

  • 14. Immunology and immunotherapy of childhood neoplasia.
    Bernstein ID, Wright PW.
    Pediatr Clin North Am; 1976 Feb 04; 23(1):93-109. PubMed ID: 815873
    [No Abstract] [Full Text] [Related]

  • 15. Specific immunotherapy with neuraminidase-modified leukemic cells: experimental and clinical trials.
    Bekesi JG, Holland JF, Roboz JP.
    Med Clin North Am; 1977 Sep 04; 61(5):1083-100. PubMed ID: 330972
    [Abstract] [Full Text] [Related]

  • 16. Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulants.
    Mastrangelo MJ, Berd D, Bellet RE.
    Ann N Y Acad Sci; 1976 Sep 04; 277(00):94-123. PubMed ID: 793490
    [No Abstract] [Full Text] [Related]

  • 17. [Immunotherapy of cancer with BCG].
    Yamamura Y, Azuma I.
    Nihon Rinsho; 1974 Mar 04; 32(3):542-53. PubMed ID: 4603604
    [No Abstract] [Full Text] [Related]

  • 18. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
    Mathé G, Halle-Pannenko O, Bourut C, Hiu IJ.
    Johns Hopkins Med J Suppl; 1974 Mar 04; 3():85-102. PubMed ID: 4154074
    [No Abstract] [Full Text] [Related]

  • 19. Nonspecific immunotherapy of malignant tumors.
    Milas L, Withers HR.
    Radiology; 1976 Jan 04; 118(1):211-8. PubMed ID: 1105663
    [Abstract] [Full Text] [Related]

  • 20. Cutaneous delayed hypersensitivity responses to tumor-associated and other antigens in acute leukemia.
    Char DH, Lepourhiet BG, Herberman RB.
    Int J Cancer; 1973 Sep 15; 12(2):409-19. PubMed ID: 4524930
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.